Dr. Jiachen Shen is a medical doctoral student at Harbin Medical University specializing in nanomedicine, with a research focus on the design and biomedical application of mesoporous silica nanoparticles (MSN) for targeted drug delivery and anti-vascular therapies. Her notable publication, Surface Modification and Pore Size Regulation of MSN as Functional Aflibercept Carrier for Anti-Vascular Migration, highlights her expertise in optimizing MSN surface properties and pore structures to enhance drug-loading efficiency, controlled release, and therapeutic performance. This work demonstrates how functionalized MSN can improve the delivery of aflibercept, a vital anti-angiogenic agent, offering promising implications for treating diseases such as cancer and age-related macular degeneration. Dr. Shen played a central role in conceptualizing the study framework, refining MSN modification strategies, designing anti-vascular migration experiments, and creating detailed visual representations that clarified complex mechanisms. Collaborating with the Faculty of Life Science and Medicine at Harbin Institute of Technology, she has contributed to advancing interdisciplinary nanomedical research. Her growing academic impact is evidenced by 37 citations from 37 documents, two research publications, and an h-index of 2. Dr. Shen’s innovative research and commitment to advancing therapeutic nanotechnology exemplify her potential as a future leader in precision medicine and biomedical innovation.